Suvaxyn Circo
ATC code
Species
Pigs (for fattening).
Indications
For active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (PCV2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with PCV2.
Onset of immunity: 3 weeks.
Duration of immunity: 23 weeks.
Dose to be administered and administration route
Intramuscular use.
Administer one dose of 2 ml to pigs in the neck behind the ear.
Vaccination schedule:
One injection from 3 weeks of age.
Shake well before administration and intermittently during the process of vaccination.
The use of a multi-dosing syringe is recommended. Use vaccination devices according to the manufacturer’s instructions. The vaccine is to be administered aseptically. During storage, a slight black deposit may appear and the emulsion may separate into two distinct phases. Upon shaking, the black deposit disappears and the emulsion becomes homogenous again.
Adverse reactions
Pigs (for fattening):
|
Very common (>1 animal / 10 animals treated): |
Elevated temperature1 Injection site inflammation2, Injection site pain3, Injection site reddening3, Injection site swelling3 |
|
Uncommon (1 to 10 animals / 1,000 animals treated): |
Hypersensitivity reactions (e.g. depression, diarrhoea or vomiting)4 |
|
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Anaphylaxis5 |
1Transient; observed during the first 24 hours after vaccination. On average 1° C but may exceed 2° C in individual pigs. This resolves spontaneously within 48 hours without treatment.
2Post-mortem examination of the injection site, performed 4 weeks after the administration of a repeated single dose of the vaccine very commonly revealed a mild lymphocytic-granulomatous inflammatory response.
3May last up to 2 days.
4Normally resolve without treatment.
5 In case of such reactions, appropriate treatment is recommended. Reporting adverse events is important.
It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
